FIELD: pharmaceutical chemistry.
SUBSTANCE: invention relates to the field of pharmaceutical chemistry, specifically to a method for the production of a derivative based on amino acid, characterized by the formula (I). The method includes interaction of compounds characterized by structural formulas (II), (III), and (IV), respectively, in the presence of methanol, with subsequent treatment of a reaction mixture, with further evaporation of a solvent under vacuum. The compound is recrystallized using acetone to obtain a final product. In the specified formulas, R is CH2C(=O)OCH3.
EFFECT: proposed method allows for obtainment of a new derivative of the formula (I), possibly having inhibitory activity relatively to acetylcholinesterase.
1 cl, 8 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING AN ACETYLCHOLINESTERASE (AChE) INHIBITOR AND INHIBITOR PRODUCED BY THE METHOD | 2021 |
|
RU2779555C1 |
| METHOD FOR OBTAINING A NEW AMINO ACID-BASED DERIVATIVE AND AN ACETYLCHOLINESTERASE INHIBITOR (ACHE) BASED ON IT | 2021 |
|
RU2774827C1 |
| COMBINATION OF 5-HT-RECEPTOR ANTAGONIST AND ACETYLCHOLINESTERASE INHIBITOR FOR USE IN TREATMENT OF ALZHEIMER'S DISEASE IN SUBPOPULATION OF PATIENTS THAT ARE CARRIERS OF ApoE4 ALLELES | 2018 |
|
RU2776366C2 |
| COMPOSITIONS CONTAINING VORTIOXETINE AND DONEPEZIL | 2013 |
|
RU2635528C2 |
| COMPOSITIONS, CONTAINING CHOLINESTERASE INHIBITOR FOR TREATING COGNITIVE DISORDERS | 2010 |
|
RU2607946C2 |
| THERAPEUTIC AGENT FOR TREATMENT OF DEMENTIA, WHICH IS COMBINATION OF PYRAZOLOQUINOLINE DERIVATIVE AND MEMANTINE | 2018 |
|
RU2784428C2 |
| COMBINED MEDICATION FOR WEIGHT-REDUCING TREATMENT | 2004 |
|
RU2363458C2 |
| TACRINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS | 2004 |
|
RU2402545C2 |
| COMBINATION OF mGluR2 RECEPTOR ANTAGONIST AND AChE ENZYME INHIBITOR FOR ACUTE ANDN/OR CHRONIC NEURALGIC DISEASES | 2004 |
|
RU2357734C2 |
| DRUG FOR PREVENTION OR TREATMENT OF BRAIN ATROPHY | 2018 |
|
RU2759727C2 |
